JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (6): 23-27.doi: 10.6040/j.issn.1671-7554.0.2015.083

Previous Articles     Next Articles

The role of miR-485-5p in human colorectal cancer HCT116 cell invasion by regulating survivin expression

ZENG Renren, ZHANG Junhua, ZHANG Yinxu   

  1. Department of General Surgery, First Affiliated Hospital of Liaoning Medical University, Jinzhou 121001, Liaoning, China
  • Received:2015-01-23 Revised:2015-04-23 Online:2015-06-10 Published:2015-06-10

PDF (PC)

208

Abstract: Objective To identify the role of miR-485-5p in human colorectal cancer HCT116 cell invasion. Methods HCT116 cells were cultured in vitro, and cellular morphology was observed with phase contrast microscope. The miR-485-5p was predicted with bioinformatics and identified with dual luciferase report system. Expressions of miR-485-5p and survivin were determined with Real-time PCR and Western blotting after transfection of miR-485-5p mimics. The invasion of HCT116 cells was detected in vitro with transwell chamber. Results Survivin expression was positive as detected by immunofluorescence cytochemistry. Dual luciferase reporter system indicated that miR-485-5p inhibited survivin expression by binding to 3'UTR of survivin mRNA. Real-time PCR and Western blotting showed that over-expression of miR-485-5p down-regulated survivin expression. The invasion of HCT116 cells was suppressed by over-expression of miR-485-5p. Conclusion The miR-485-5p may negatively regulate survivin expression by binding to its 3'UTR in human colorectal cancer HCT116 cells and inhibit cell invasion.

Key words: Colorectal neoplasm, MiRNA, Survivin, HCT116 cells

CLC Number: 

  • R735.3
[1] 李道娟, 李倩, 贺宇彤. 结直肠癌流行病学趋势[J]. 肿瘤防治研究, 2015, 42(3): 305-310. LI Daojuan, LI Qian, HE Yutong. The incidence trends of colorectal cancer[J]. Cancer Research on Prevention and Treatment, 2015, 42(3): 305-310.
[2] 万德森. 结直肠癌流行病学与预防[J]. 中国中西医结合外科杂志, 2011, 17(1): 3-6. WAN Desen. Epidemiology and prevention of colorectal cancer[J]. Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 2011, 17(1): 3-6.
[3] Ye Q, Yao G, Zhang M, et al. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling[J]. Carcinogenesis, 2015, 36(3): 318-326.
[4] Bastos LG, de Marcondes PG, de-Freitas-Junior JC, et al. Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/β-catenin pathway[J]. J Cell Biochem, 2014, 115(12): 2175-2187.
[5] Zhou X, Lin C. Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis[J]. World J Surg Oncol, 2015, 13(1): 461. doi: 10.1186/s12957-015-0461-5.
[6] Kim ST, Sohn I, DO IG, et al. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer[J]. Cancer Genomics Proteomics, 2014, 11(5): 259-266.
[7] Chua JH, Armugam A, Jeyaseelan K. MicroRNAs: biogenesis,function and applications[J]. Curr Opin Mol Ther, 2009, 11(2): 189-199.
[8] Carpi S, Fogli S, Giannetti A, et al. Theranostic properties of a survivin-directed molecular beacon in human melanoma cells[J]. PLoS One, 2014, 9(12): e114588. doi: 10.1371/journal.pone.0114588.
[9] Pavlidou A, Kroupis C, Dimas K. Association of survivin splice variants with prognosis and treatment of breast cancer[J]. World J Clin Oncol, 2014, 5(5): 883-894.
[10] Ren YQ, Zhang HY, Su T, et al. Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma[J]. Eur Rev Med Pharmacol Sci, 2014, 18(20): 3063-3068.
[11] Yamak N, Yaykasli KO, Yilmaz U, et al. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population[J]. Asian Pac J Cancer Prev, 2014, 15(20): 8963-8967.
[12] Xiaoyuan C, Longbang C, Jinghua W, et al. Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer[J]. Ir J Med Sci, 2010, 179(3): 327-335.
[13] Sprenger T, Rödel F, Beissbarth T, et al. Failure of downregulation of surviving following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival[J]. Clin Cancer Res, 2011, 17(6): 1623-1631.
[14] Di Stefano AB, Iovino F, Lombardo Y, et al. Survivin is regulated by interleukin-4 in colon cancer stem cells[J]. J Cell Physiol, 2010, 225(2): 555-561.
[15] Langevin SM, Christensen BC. Let-7 microRNA-binding-site polymorphism in the 3'UTR of KRAS and colorectal cancer outcome: a systematic review and meta-analysis[J]. Cancer Med, 2014, 3(5): 1385-1395.
[16] Rokavec M, ner MG, Li H, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis[J]. J Clin Invest, 2015, 125(3): 1362. doi: 10.1172/JCI81340.
[17] Zhou W, Li X, Liu F, et al. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro[J]. Acta Biochim Biophys Sin, 2012, 44(10): 838-846.
[1] HUANG Fang, KANG Rui, TUN Chun-Lin. Expressions of VEGF-C，nuclear factor-kappa B and  Survivin in nasopharyngeal carcinoma and their clinical implications [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 83-.
[2] WANG Lin-Lin, SUN Mei-Li, SUN Yu-Ping, ZHANG Nan, LIU Chuan-Yong. Expressions of α-Tubulin and γ-Tubulin in human Glioma and their relation with Survivin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 103-.
[3] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47-52.
[4] DENG Ke, LIU Yi, GAI Zhongtao. Susceptibility of mesenchymal stem cells to enterovirus 71 and differential expression of miRNA [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 25-31.
[5] LIU Tong, ZHANG Xin, WANG Chuanxin. Significance of IRX5 mRNA in the diagnosis and prognosis of colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 69-74.
[6] YU Fei, LIU Shaozhuang, ZHONG Mingwei, HUANG Xin, JIAO Jie, HU Sanyuan, YU Wenbin. Metabolomics analysis of colorectal cancer based on GC-TOF-MS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 60-68.
[7] CAO Kai, WANG Chaoqun, ZHENG Maojin, WU Yongping. Correlation between TLR4, MyD88 and ERK1/2 expressions and EBV infected colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 75-79.
[8] LI Shuai, LI Dinuo, YUAN Chaofan, LIANG Xu, WANG Yubin. Inhibitory effect of miR-98-5p on human gastric cancer MGC803 cell proliferation by regulating AKT2 expression [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 27-31.
[9] YU Shuping, LI Xuefei, WANG Dan, WANG Yukun. Expressions of PDCD4 and survivin in condyloma acuminatum, Bowenoid papulosis, Bowen disease and squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 82-86.
[10] GU Xu, WANG Xiaqing, REN Wanhua, QIN Chengyong, HAN Guoqing. Expression and clinical significance of NPRL2 and Survivin in hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 68-72.
[11] YAO Dongxue, ZHAO Qi, QIN Chengyong. Clinical significance of miRNA-206 expression in gastric stromal tumor [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 67-70.
[12] LI Hongxia, DONG Lei, JIANG Jiong, WANG Xinyang. Effects of peptide YY on apoptosis of human pancreatic cancer cell line Miapaca-2 in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 7-11.
[13] WU Jinhua1, YANG Xihu1, LIU Zhenzhong2, DING Xiaojun1, XU Jianhui1. Expression  and significance of Survivin in human oral squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 89-92.
[14] ZHU Shou-rong1， ZHANG Rui2， CAO Yong-qian1， FENG Zhang1， WANG Yi-bing1. The effect of the survivin-siRNA targeting lentivirus vector on human malignant melanoma cell line A375 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 54-57.
[15] ZHAI Shan-shan1, DING Bu-tong2, LI Hai-xia3, CHEN Yun1, CHANG Ya-li1, SANG Tan1, GUO Nong-jian1. Differential expressions of microRNAs in the CD138+ cells of multiple myeloma patients with deletion of chromosome 13 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 80-84.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd